Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05584267
PHASE2

Immune Treatment of Brain Metastasis of Lung Cancer Combined With Large-segmentation Precision Radiotherapy

Sponsor: Hunan Province Tumor Hospital

View on ClinicalTrials.gov

Summary

This is a prospective multicenter clinical study. This study aims to construct an auxiliary decision-making system for lung cancer immunotherapy combined with radiotherapy by fusing three modes of imagomics, clinicopathological features, and molecular pathological features.

Official title: Multi-omics Evaluation System and Preferred Mode of Immune Treatment of Brain Metastasis of Lung Cancer Combined With Large-segmentation Precision Radiotherapy

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

140

Start Date

2022-12-25

Completion Date

2026-12-31

Last Updated

2024-05-30

Healthy Volunteers

No

Interventions

RADIATION

radiotherapy

Different cohorts received different doses of radiotherapy

DRUG

Chemotherapy + immunotherapy

Chemotherapy + immunotherapy

Locations (1)

Hunan Cancer Hospital

Changsha, Hunan, China